Eye drop maker to merge with a retinal gene therapy startup from Spark co-founder

The eye drop mak­er Ocuphire Phar­ma and start­up Opus Ge­net­ics are merg­ing in an all-stock deal, the com­pa­nies told End­points News.

Ocuphire $OCUP will ac­quire …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.